THEON's Strategic Move to Acquire Exosens Stake
In a bold move highlighting its growth strategy, Theon International Plc (THEON) has made a definitive agreement to acquire a 9.8% stake in Exosens SA (EXOSENS) valued at €268.7 million, equating to €54.0 per share. This acquisition positions THEON as the second largest shareholder in EXOSENS, enhancing their strategic partnership.
Understanding Exosens: A Leader in Technology
Exosens is celebrated for its expertise in advanced electro-optical technologies, which include light amplification, detection, and imaging systems. With this transaction, THEON aims to strengthen its influence in the field of optical technology while securing a significant presence in Exosens's innovative pursuits.
Transaction Details and Future Outlook
The closing of the acquisition is contingent upon regulatory notifications across multiple countries and is anticipated to conclude by early Q1 2026. This timeline reflects the complexities often involved in strategic investments within regulated markets.
Financial Synergies: Support from UBS and Citibank
For this significant acquisition, UBS Europe SE and Citibank Europe PLC will provide a bridge facility to THEON, ensuring adequate capital flow during the transition phase. The financial strategy includes refinancing this facility through a mix of debt and newly issued equity, supporting a robust capital framework.
Leadership Insights on the Transaction
Christian Hadjiminas, Founder and CEO of THEON, expressed enthusiasm regarding this acquisition, stating, "THEON and EXOSENS have been close commercial partners for years, having been awarded landmark contracts in Europe and the Middle East. We are committed to our long-standing commercial relationship with EXOSENS, which is established through existing contractual arrangements." This statement underscores the deep-rooted cooperation between the two companies.
Contact Information for Inquiries
For further inquiries, stakeholders and interested parties can reach:
Investor Relations: Nikos Malesiotis
E-Mail: ir@theon.com
Tel: +30 210 6772290
Media Contact: Elli Michou
E-Mail: press@theon.com
Tel: +30 210 6728610
About THEON GROUP
THEON GROUP is dedicated to developing and manufacturing cutting-edge night vision and thermal imaging systems for Defense and Security applications globally. Founded in 1997 in Greece, THEON GROUP has established a prominent position within the sector, operating through subsidiaries and production facilities across multiple countries including Greece, Cyprus, Germany, and more. The firm has delivered over 220,000 systems, enhancing operational capabilities for Armed and Special Forces in 71 countries.
The Future of THEON
As the acquisition progresses, it is evident that THEON is positioning itself for further growth and expansion in high-tech sectors, emphasizing innovation and strategic partnerships that enhance operational effectiveness and market presence.
Frequently Asked Questions
What does the acquisition of Exosens mean for THEON?
This acquisition allows THEON to strengthen its market position and expand its technology portfolio, becoming the second largest shareholder in Exosens.
When is the expected closing date for the transaction?
The transaction is expected to close in early Q1 2026, pending regulatory notifications.
What sectors does THEON specialize in?
THEON specializes in developing and manufacturing night vision and thermal imaging systems primarily used in defense and security applications.
Who provided financial and legal advice for this acquisition?
UBS Europe SE served as the sole financial advisor, while Clifford Chance provided legal advice for THEON in this transaction.
How can stakeholders contact THEON for more information?
Stakeholders can reach out to investor relations or media contacts via the provided email addresses and phone numbers.
